Hearts2Hearts establece un nuevo récord de ventas en su primera semana con Lemon Tang

El grupo femenino novato de SM Entertainment ha superado su propio récord de ventas en la primera semana con el miniálbum Lemon Tang.

Hearts2Hearts regresó la semana pasada con el nuevo miniálbum Lemon Tang y su sencillo principal del mismo nombre.

Hanteo Chart informó que Lemon Tang vendió 592,312 copias durante su primera semana, del 22 al 28 de junio.

Esta cifra supera el récord anterior del grupo de 425,146 copias establecido por su miniálbum anterior, Focus.

Artículos relacionados

BTS celebrates 'Arirang' topping Billboard 200 for second week, first for K-pop.
Imagen generada por IA

BTS's 'Arirang' Tops Billboard 200 for Second Straight Week, First for K-pop Album; Earns 187,000 Units

Reportado por IA Imagen generada por IA

BTS's fifth studio album 'Arirang' held the No. 1 spot on the Billboard 200 for a second consecutive week on the chart dated April 11 (tracking week ending April 2), becoming the first K-pop album to achieve this feat with 187,000 equivalent album units.

Hearts2Hearts shattered their previous first-week sales mark just two days after releasing the mini album Lemon Tang on June 22.

Reportado por IA

K-pop girl group aespa entered the U.S. Billboard 200 at No. 9 with its second full-length album 'Lemonade'. This marks the group's third top 10 entry on the chart.

Ella Langley's album Dandelion held the top spot on the Billboard 200 for a second week, according to Luminate data. The set earned 106,000 equivalent album units in the United States for the week ending April 23. TOMORROW X TOGETHER debuted at No. 3 with its new release.

Reportado por IA

South Korean boy group BTS's 'ARIRANG' has held the No. 1 spot on the U.S. Billboard 200 for a third consecutive week, a first in K-pop history. Billboard's chart preview on Sunday (U.S. time) showed the album ahead of Morgan Wallen's 'I'm the Problem' and Ye's 'Bully,' formerly known as Kanye West.

Este sitio web utiliza cookies

Utilizamos cookies para análisis con el fin de mejorar nuestro sitio. Lee nuestra política de privacidad para más información.
Rechazar